Benefits of nanoencapsulation for the hypercin-mediated photodetection of ovarian micrometastases
Authors:
- Florence DelieFDFlorence Delie
- Robert GurnyRGRobert Gurny
- Norbert LangeNLNorbert Lange
- 1 February 2009
- journal article
- Published by Elsevier in European Journal of Pharmaceutics and Biopharmaceutics
- Vol. 71 (2) , 207-213
Abstract
No abstract availableKeywords
This publication has 64 references indexed in Scilit:
- Clinically Relevant Reduction in Risk of Recurrence of Superficial Bladder Cancer Using 5-Aminolevulinic Acid-Induced Fluorescence Diagnosis: 8-Year Results of Prospective Randomized StudyUrology, 2007
- Estimates of the cancer incidence and mortality in Europe in 2006Annals of Oncology, 2007
- Cancer Statistics, 2007CA: A Cancer Journal for Clinicians, 2007
- Worldwide burden of gynaecological cancer: The size of the problemBest Practice & Research Clinical Obstetrics & Gynaecology, 2006
- Ovarian Cancer Metastasis: Integrating insights from disparate model organismsNature Reviews Cancer, 2005
- Cancer of the OvaryNew England Journal of Medicine, 2004
- Photodiagnosis and fluorescence imaging in clinical practicePhotodiagnosis and Photodynamic Therapy, 2004
- The History of Photodetection and Photodynamic Therapy¶Photochemistry and Photobiology, 2001
- FIGO staging classifications and clinical practice gudelines in the management of gynecologic cancersInternational Journal of Gynecology & Obstetrics, 2000
- In VivoFluorescence Detection of Ovarian Cancer in the NuTu-19 Epithelial Ovarian Cancer Animal Model Using 5-Aminolevulinic Acid (ALA)Gynecologic Oncology, 1997